A new pill, relugolix–estradiol–norethisterone (also known as Ryeqo), has been approved for NHS use in England and could be a ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...

The UK's NHS has approved a first daily pill, relugolix combination therapy, to treat endometriosis symptoms. The new ...

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, ...

While, on average, it takes eight years to be diagnosed with endometriosis, there are, thankfully, new breakthroughs in ...

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily ...

But now the NHS England has approved a daily pill that could help manage pain and other symptoms for those living with the condition. The new tablet, known as relugolix combination therapy or Ryeqo, ...

The treatment, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), works by blocking specific hormones that contribute to endometriosis, while also ...

The drug, also called Relugolix, blocks signals from the brain that tell the ovaries to make oestrogen, a hormone that fuels ...

The drug that has been approved by the National Institute for Health and Care Excellence (Nice) is called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo).